These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9069520)

  • 61. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
    Eto M; Sato T; Watanabe K; Iwashima Y; Makino I
    Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages.
    Klein RL; Lyons TJ; Lopes-Virella MF
    Metabolism; 1989 Nov; 38(11):1108-14. PubMed ID: 2554094
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
    Imari Y; Koga S; Ibayashi H
    Metabolism; 1988 Dec; 37(12):1134-8. PubMed ID: 3193900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of double pre-beta lipoproteinemia in hyperlipidemic patients is influenced by gender, menopausal status, and ApoE phenotype.
    Cohn JS; Giroux LM; Fortin LJ; Davignon J
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2630-7. PubMed ID: 9409236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.
    Hozumi Y; Kawano M; Saito T; Miyata M
    Endocr J; 1998 Apr; 45(2):255-9. PubMed ID: 9700480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia.
    Gorshkova IN; Atkinson D
    JSM Atheroscler; 2017; 2(2):. PubMed ID: 28597004
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coenzyme Q10, antioxidant status and ApoE isoforms.
    Battino M; Giunta S; Galeazzi L; Galeazzi R; Mosca F; Santolini C; Principi F; Ferretti G; Bacchetti T; Bencivenga R; Piani M; Riganello G; Littarru GP
    Biofactors; 2003; 18(1-4):299-305. PubMed ID: 14695947
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced binding of apolipoprotein A-I variants associated with hypertriglyceridemia to triglyceride-rich particles.
    Gorshkova IN; Atkinson D
    Biochemistry; 2011 Mar; 50(12):2040-7. PubMed ID: 21288012
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins.
    Lyons TJ; Klein RL; Baynes JW; Stevenson HC; Lopes-Virella MF
    Diabetologia; 1987 Dec; 30(12):916-23. PubMed ID: 3436488
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Importance of apo E2 heterozygosity, insulin, and hypertriglyceridemia for very low density lipoproteins.
    Ozçürümez M; Westphal S; Nauck M; Wieland H; Luley C
    Atherosclerosis; 1997 Jul; 132(2):255-7. PubMed ID: 9242973
    [No Abstract]   [Full Text] [Related]  

  • 71. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia.
    Johansen CT; Wang J; Lanktree MB; McIntyre AD; Ban MR; Martins RA; Kennedy BA; Hassell RG; Visser ME; Schwartz SM; Voight BF; Elosua R; Salomaa V; O'Donnell CJ; Dallinga-Thie GM; Anand SS; Yusuf S; Huff MW; Kathiresan S; Cao H; Hegele RA
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1916-26. PubMed ID: 21597005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Remnant lipoproteins as therapeutic targets.
    Havel RJ
    Curr Opin Lipidol; 2000 Dec; 11(6):615-20. PubMed ID: 11086335
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors.
    Spagnuolo CM; Hegele RA
    Expert Opin Pharmacother; 2023 Jun; 24(9):1013-1020. PubMed ID: 37114828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Post-prandial triglyceride-rich lipoprotein metabolism: possible role of sialilated apolipoprotein E isoproteins.
    Ito H; Naito C; Suzuki Y; Nakamura K; Nagase M
    Eur J Clin Invest; 1994 Jul; 24(7):468-75. PubMed ID: 7957504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
    Mabuchi H; Itoh H; Takeda M; Kajinami K; Wakasugi T; Koizumi J; Takeda R; Asagami C
    Metabolism; 1989 Feb; 38(2):115-9. PubMed ID: 2492364
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.
    Tolosa M; Peiró S; Real JT; Cano A; Ascaso JF; Carmena R
    Maturitas; 2001 Nov; 40(2):173-81. PubMed ID: 11716996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Failure of exogenous apoprotein E-3 to enhance cholesterol egress from J-774 murine macrophages in culture.
    Granot E; Eisenberg S
    Atherosclerosis; 1995 Apr; 114(1):115-22. PubMed ID: 7605370
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese.
    Sano R; Abe R; Oikawa S; Fujii Y; Hori S; Suzuki N; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Mar; 154(3):297-303. PubMed ID: 3376106
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combination of apolipoprotein E2 and lipoprotein lipase heterozygosity causes severe hypertriglyceridemia during pregnancy.
    Hiéronimus S; Benlian P; Bayer P; Bongain A; Fredenrich A
    Diabetes Metab; 2005 Jun; 31(3 Pt 1):295-7. PubMed ID: 16142021
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum apolipoprotein profile of hypertriglyceridemic patients with chronic renal failure on hemodialysis: a comparison with type IV hyperlipoproteinemic patients.
    Averna MR; Barbagallo CM; Galione A; Carroccio A; Labisi M; Marino G; Montalto G; Notarbartolo A
    Metabolism; 1989 Jul; 38(7):601-2. PubMed ID: 2739572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.